Sort
51,593 grants matching “hepatitis”
New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo
$420,000Eva Billerbeck · Albert Einstein College Of Medicine · R01 · FY2024 · AI
New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo
$420,000Eva Billerbeck · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Delivery of Oligonucleotides to Hepatocytes In Vivo
$419,969Mirus Bio Corporation · R44 · FY2004 · DK
Control of vesicular trafficking in the hepatocyte.
$419,963Allan W Wolkoff · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DK
A Precision Targeted Therapeutics for Nonalcoholic Fatty Liver Disease
$419,955Wanqing Liu · Wayne State University · R01 · FY2023 · DK
Role of Inflammation in tumor promotion and progression
$419,899Michael Karin · University Of California, San Diego · R01 · FY2013 · CA
Novel viruses and viral dynamics in multiple transfusion recipients
$419,889Amit Kapoor · Columbia University Health Sciences · R01 · FY2014 · HL
Inherited Variations In Drug Metabolizing Enzymes
$419,836Richard M Weinshilboum · Mayo Clinic Rochester · R01 · FY2018 · GM
Inherited Variations In Drug Metabolizing Enzymes
$419,836Richard M Weinshilboum · Mayo Clinic Rochester · R01 · FY2019 · GM
HCV Disease Management in HIV- HCV Coinfected IDUs
$419,807Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2009 · DA
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injury
$419,802Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2015 · ES
Core D: Clinical Sciences
$419,795Jeffrey M Jacobson · Case Western Reserve University · P30 · FY2024 · AI
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)
$419,793Jodie Ann Dionne · University Of Alabama At Birmingham · R01 · FY2020 · HD
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$419,793Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2024 · DK
Role of NgBR in Hepatic Steatosis
$419,790Qing Miao · Nyu Winthrop Hospital · R01 · FY2020 · DK
Training Program in Substance Use, HIV and Related Infections
$419,786Steffanie A Strathdee · University Of California, San Diego · T32 · FY2015 · DA
Novel roles of copper in adaptive responses to hypoxia
$419,739Michael J Petris · University Of Missouri-Columbia · R01 · FY2025 · DK
In silico identification of phyto-therapies
$419,732Indra N Sarkar · Brown University · R01 · FY2016 · LM
A Novel Neural Mechanism that Mediates the Therapeutic Effects of Metformin
$419,719Makoto Fukuda · Baylor College Of Medicine · R01 · FY2022 · DK
Hepatocellular Carcinoma in Antitrypsin Deficiency
$419,691David H Perlmutter · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · DK
Hepatocellular Carcinoma in Antitrypsin Deficiency
$419,691David H Perlmutter · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK
Defining the molecular interactions within nanoparticles that enable delivery of long nucleic acids
$419,679Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2023 · EB
Type I Interferon-Regulated T Helper Development
$419,653John David Farrar · Ut Southwestern Medical Center · R01 · FY2014 · AI
Cell transplantation and inflammation
$419,580Sanjeev Gupta · Albert Einstein College Of Medicine · R01 · FY2012 · DK
Genetic Assay for Inhibitors of RNA-Protein Interactions
$419,572Advanced Genetic Systems, Inc. · R42 · FY2005 · CA